Insulet
PODD
#1018
Rank
NZ$33.40 B
Marketcap
$475.72
Share price
-0.49%
Change (1 day)
72.97%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): NZ$0.57 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$2.07 Billion. , an increase over its 2023 earnings that were of NZ$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.59 B36.72%
2023 NZ$0.43 B481.9%
2022 NZ$75.18 M-45.24%
2021 NZ$0.13 B43.35%
2020 NZ$95.76 M18.51%
2019 NZ$80.81 M41.16%
2018 NZ$57.24 M-711.95%
2017 -NZ$9.36 Million-56.85%
2016 -NZ$21.69 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$63.97 Million31.04%
2013 -NZ$48.82 Million-21.96%
2012 -NZ$62.56 Million
2010 -NZ$59.67 Million-42.38%
2009 -NZ$0.11 Billion-33.56%
2008 -NZ$0.16 Billion65.93%
2007 -NZ$93.93 Million209.75%
2006 -NZ$30.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$70.69 M-88.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.17 Billion-127.25%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.26 B 112.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.42 B 4,986.61%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.23 B 1,945.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.42 B 1,643.66%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$22.11 B 3,597.99%๐Ÿ‡บ๐Ÿ‡ธ USA